Patients with chronic obstructive pulmonary disease in the primary care setting

Pneumonologia i Alergologia Polska

Volumn 78, Issue 2, 2010, Pages 112-119

  Siatkowska, Hanna ^a   Kozielski, Jerzy ^a   Ziora, Dariusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiovascular disease; COPD; Early diagnosis; Epidemiology; General practitioner; Spirometry

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE COURSE; FEMALE; GENERAL PRACTICE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; POLAND; PREVALENCE; PRIMARY HEALTH CARE; SMOKING; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; DISEASE PROGRESSION; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLAND; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84875135837     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. World Bank/WHO Global Burden of Disease Study http:www.who.int/topics/global burden of disease; 11.2007
2. Lopez A.D., Shibuya K., Rao C. et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27: 397-412.
3. Prescott E. Tobacco-related diseases: the role of gender. Dan. Med. Bull. 2000; 47: 115-131.
4. Anto J.M., Vermeire P., Vestbo J., Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur. Respir. J. 2001; 17: 982-994.
5. Rozpoznawanie i leczenie przewlekłej obturacyjnej choroby płuc. Wytyczne Światowej Inicjatywy Zwalczania Przewlekłej Obturacyjnej Choroby Płuc (GOLD 2006). Med. Prakt. 2007; wyd. spec. 2: 13-16.
6. Meek P.A., Schwartzstein R.M., Adams L. et al. Dyspnea. Mechanisms, assessment and management: a consensus statement. Am. J. Respir. Crit. Care Med. 1999; 159: 321-340.
7. Zalecenia Polskiego Towarzystwa Chorób Płuc dotycza{ogonek}ce wykonywania badań spirometrycznych. Pneumonol. Alergol. Pol. 2006; 74 (supl. 1): 6-44.
8. Quanier P.H., Tammeling G.J., Cotes J.E. et al. Lung volumes and forced expiratory flows. Eur. Respir. J. 1993; supl. 6: 5-49.
9. Enright P.L., Kaminsky D.A. Strategies for screening for chronic obstructive pulmonary disease. Respir. Care 2003; 48: 1194-1201.
10. Europejskie Towarzystwo Kardiologiczne. Europejskie wytyczne dotycza{ogonek}ce prewencji chorób układu kra{ogonek}żenia w praktyce klinicznej. Kardiol. Pol. 2004; 61 (supl. 1): 1-92.
11. Rennard S.M., Decramer P., Calverley N.B. et al. Impact of COPD in North America and Europe in 2000: subjects perspective of confronting international survey. Eur. Respir. J. 2002; 20: 799-805.
12. Zieliński J. Profilaktyka POChP. Nowe zadanie dla lekarza rodzinnego. Lekarz Rodz. 2005; 7-8: 748-756.
13. Chapman K.R. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin. Chest Med. 2004; 25: 331-341.
14. Soriano J.B., Maier W.C., Egger P. et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789-794.
15. Krawczyk K., Skucha W. Cze{ogonek}stość wyste{ogonek}powania przewlekłej obturacyjnej choroby płuc wśród przewlekle pala{ogonek}cych tytoń mieszkańców Krakowa i Proszowic. Przegl. Lek. 2000; 57: 617-618.
16. Menzin J., Brown J.S., Guadagno L. et al. Care-seeking behavior among subjects with early chronic obstructive lung disease identified through a community spirometry screening program: findings from the respiratory health promotion study (RHPS). Chest 2006; 130: 170.
17. Price D.B., Tinkelman D.G., Nordyke R.J. et al. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 2006; 129: 1531-1539.
18. Halbert R.J., Isonaka S. International Primary Care Respiratory Group (IPCRG) Guidelines. Integrating diagnostic guidelines for managing chronic respiratory diseases in primary care. Prim. Care Resp. J. 2006; 15: 13-19.
19. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist S.A., Mannico D.M. Global burden of COPD systematic review and metaanalysis. Eur. Respir. J. 2006; 28: 523-532.
20. Stratelis G., Jakobsson P., Molstad S., Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br. J. Gen. Pract. 2004; 54: 201-206.
21. Bednarek M., Pływaczewski R., Górecka D. et al. Wczesne rozpoznawanie POChP badaniem spirometrycznym u pala{ogonek}cych papierosy mieszkańców Warszawy. Pneumonol. Alergol. Pol. 2002; 70: 139-147.
22. Lubiński W., Płusa T., Mierzejewska-Zawisza J.M. et al. Early detection of COPD in mass spirometry. Eur. Respir. J. 2002; 20 (supl. 38): 123.
23. Maciejewski J. Cze{ogonek}stość wyste{ogonek}powania POChP w praktyce lekarza rodzinnego. Rozprawa doktorska, Instytut Gruźlicy i Chorób Płuc, 2007.
24. Grassi F.T., Stafford C. The use of spirometry to screen patients with chronic obstructive pulmonary disease risk factors at a military treatment facility. Chest 2006; 130: 174 S.
25. Glaab T., Banik N., Singel C., Wencker M. Guideline conformance for outpatient management of COPD in Germany. Dtsch. Med. Wochenschr. 2006; 131: 1203-1208.
26. Bashford S., Chadwick S., Ward J. et al. Identifying chronic obstructive pulmonary disease in the community-a primary care survey. Eur. Respir. J. 2002; 20 (supl. 38): 413S.
27. Damaria M., Celli B.R., Mellerova H.X., Pinto Plata V.M. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir. Care 2006; 51: 1120-1124.
28. Walker P.P., Mitchell P., Diamantea F., Warburton C.J., Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur. Respir. J. 2006; 28: 945-952.
29. Zieliński J., Roszkowski-Śliż K. Narodowy program wczesnego rozpoznawania i profilaktyki POChP. Pneumonol. Alergol. Pol. 2002; 70: 125-129.
30. Faulconer E.R., de Lusignan S. An eight-step method for assessing diagnostic data quality in practice: chronic obstructive pulmonary disease as an exemplar. Inform. Prim. Care 2004; 12: 243-254.
31. Lindberg A., Bjerg-Backlund A., Ronmark E., Larsson L.G., Lundback B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir. Med. 2006; 100: 264-272.
32. Niepsuj G., Kozielski J., Niepsuj K., Ziora D., Polońska A., Cieślicki J. Przewlekła obturacyjna choroba płuc wśród mieszkańców miasta Zabrze. Wiad. Lek. 2002; 55 (supl. 1): 354-359.
33. Menezes A.M., Perez-Padilla R., Jardim J.R. et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
34. WordHealthOrganization. TobaccoAtlas. http://www.who.int/tobacco/ global_data/country_profiles/amro/en/ Accessed 15, 2005.11.2007.
35. Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
36. Fukuchi Y., Nishimura M., Ichinose M. et al. Prevalence of chronic obstructive pulmonary disease in Japan: the Nippon COPD epidemiology study. Respirology 2004; 9: 458-465.
37. Pena V.S., Miravitlles M., Gabriel R. et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
38. Sin D.D., Man S.F. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can. J. Physiol. Pharmacol. 2007; 85: 141-147.
39. Lee J.H., Leen D.S., Kim E.K. Simvastatin inhibits cigarette smoking induced emphysema and pulmonary hypertension in rat lungs. Am. J. Respir. Crit. Care Med. 2005; 172: 987-993.
40. Dhungel S., Paudel B., Shah S. Study of prevalence of hypertension in Chronic Obstructive Pulmonary Disease patients admitted at Nepal Medical College and Teaching Hospital. Nepal Med. Coll. J. 2005; 7: 90-92.
41. Hozawa A., Billings J.L., Shahar E. et al. Lung function and ischemic stroke incidence. The atherosclerosis risk in communities study. Chest 2006; 130: 1642-1649.
42. Lofdahl C.G., Postma D.S., Pride N.B., Boe J., Thoren A. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur. Respir. J. 2007; 29: 1115-1119.
43. Sidney S., Sorel M., Quesenberry C.P., De Luise C., Lanes S., Eisner M.D. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanent Medical Care Program. Chest 2005; 128: 2068-2075.
44. Rascon-Aguilar I.E., Pamer M., Wludyka P., Cury J., Coultas D., Lambiase L.R. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006; 130: 1096-1101.
45. Phulpoto M.A., Qayyum S., Rizvi N., Khuhawar S.M. Proportion of gastroesophageal reflux symptoms in patients with chronic obstructive pulmonary disease. J. Pak. Med. Assoc. 2005; 55: 276-279.
46. Casanova C., Daudet J.S., del Valle Velasco M., Martin J.M., Aguirre-Jaime A., de Torres J.P. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur. Respir. J. 2004; 23: 841-845.